Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors
- 1 May 1999
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 55 (2), 167-175
- https://doi.org/10.1023/a:1006262324959
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancyBreast Cancer Research and Treatment, 1996
- Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinomaHistopathology, 1995
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Do we really need prognostic factors for breast cancer?Breast Cancer Research and Treatment, 1994
- Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factorsInternational Journal of Cancer, 1991
- The Geometric Interpretation of Correspondence AnalysisJournal of the American Statistical Association, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977